Skip to main content
SpringerLink
Log in

Pathologic Features, Grading, and Variants of Follicular Lymphoma

  • Chapter
  • First Online:
Follicular Lymphoma

  • 676 Accesses

Abstract

Follicular lymphoma (FL) encompasses a wide spectrum of clinical and pathologic manifestations ranging from a mostly indolent neoplasm to more aggressive types. It was initially described as a nodular lymphoma predominantly composed of B-lymphocytes residing in the germinal center which were morphologically defined as small centrocytes and large centroblasts. The genetic basis of the disease is the presence of the translocation t(14;18)(q32;q21)/IGH-BCL2 that encodes for a fusion protein with potent antiapoptotic characteristic. Although mainly an indolent lymphoma, in a substantial minority of cases, transformation to a more aggressive lymphoma occurs. Multiple variants of follicular lymphoma have been described mainly based on clinical manifestations, patterns of organ involvement, age of patients, and cytogenetic or molecular abnormalities. This has led to the formal recognition of variants of follicular lymphoma such as testicular, primary cutaneous, or duodenal follicular lymphoma. Some of these variants along with high-grade FL may lack t(14;18)(q32;q21)/IGH-BCL2. Similarly, pediatric-type FL (PTFL) affects children and lacks t(14;18)(q32;q21)/IGH-BCL2. A rare variant, diffuse FL, by definition, lacks follicles so it challenges the essential concept that defines follicular lymphoma as a nodular neoplasm. In this chapter, we cover the morphologic spectrum, immunophenotype, cytogenetics, and molecular genetic features as well as the common variants of follicular lymphoma.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Medeiros LJ, O’Malley DP, Caraway NP, Vega F, Elenitoba-Johnson KJS, Lim MS. Tumors of the lymph nodes and spleen. In: Atlas of tumor pathology, Series 4. AFIP; 2017.

    Google Scholar 

  2. Jaffe ES, Harris NL, Swerdlow SH, Ott G, Nathwani BN, Jong Dd, et al. Follicular lymphoma. In: Swerdlow SH, Campo E, Harris NH, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th ed. Lyon: IARC; 2017. p. 266–77.

    Google Scholar 

  3. Brill NE, Baehr G, Rosenthal N. Generalized giant lymph follicle hyperplasia of lymph nodes and spleen; a hitherto undescribed type. Am J Med. 1952;13:570–4.

    Article  CAS  PubMed  Google Scholar 

  4. Symmers D. Lymphoid diseases; Hodgkin’s granuloma, giant follicular lymphadenopathy, lymphoid leukemia, lymphosarcoma and gastrointestinal pseudoleukemia. Arch Pathol (Chic). 1948;45:73–131.

    CAS  Google Scholar 

  5. Custer RP. Borderlands dim in malignant disease of the blood-forming organs. Radiology. 1953;61:764–70.

    Article  CAS  PubMed  Google Scholar 

  6. Cohen SE, Bergstrom VW. Giant follicular lymphoblastoma. Am J Clin Pathol. 1946;16:22–39.

    Article  CAS  PubMed  Google Scholar 

  7. Hicks EB, Rappaport H, Winter WJ. Follicular lymphoma; a re-evaluation of its position in the scheme of malignant lymphoma, based on a survey of 253 cases. Cancer. 1956;9:792–821.

    Article  CAS  PubMed  Google Scholar 

  8. Gall EA, Mallory TB. Malignant lymphoma: a clinico-pathologic survey of 618 cases. Am J Pathol. 1942;18:381–429.

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Lennert K. Morphology and classification of malignant lymphomas and so-called reticuloses. Acta Neuropathol Suppl. 1975;Suppl 6:1–16.

    Google Scholar 

  10. Lukes RJ, Collins RD. New approaches to the classification of the lymphomata. Br J Cancer Suppl. 1975;2:1–28.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. National Cancer Institute sponsored study of classifications of non-Hodgkin’s lymphomas: summary and description of a working formulation for clinical usage. The non-Hodgkin’s lymphoma pathologic classification project. Cancer. 1982;49:2112–35.

    Google Scholar 

  12. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361–92.

    Article  CAS  PubMed  Google Scholar 

  13. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. World Health Organization classification of tumors. Pathology and genetics of tumors of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008.

    Google Scholar 

  14. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J. WHO Classification of tumours of haematopoietic and lymphoid tissues. Revised 4th ed. Lyon (France): IARC; 2017.

    Google Scholar 

  15. Dave SS, Wright G, Tan B, Rosenwald A, Gascoyne RD, Chan WC, et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med. 2004;351:2159–69.

    Article  CAS  PubMed  Google Scholar 

  16. Gradowski JF, Jaffe ES, Warnke RA, Pittaluga S, Surti U, Gole LA, Swerdlow SH. Follicular lymphomas with plasmacytic differentiation include two subtypes. Mod Pathol. 2010;23:71–9.

    Article  PubMed  Google Scholar 

  17. Miranda RN. Extranodal follicular lymphoma. In: Medeiros LJ, editor. Diagnostic pathology lymph nodes and spleen with extranodal lymphomas. 1st ed. Altona: Amirsys, Inc; 2011. p. 7-12 to 7-23.

    Google Scholar 

  18. Medeiros LJ, Miranda RN. Diagnostic pathology: lymph nodes and extranodal lymphomas. 2nd ed. Salt Lake City: Elsevier; 2017.

    Google Scholar 

  19. Kojima M, Matsumoto M, Miyazawa Y, Shimizu K, Itoh H, Masawa N. Follicular lymphoma with prominent sclerosis (“sclerosing variant of follicular lymphoma”) exhibiting a mesenteric bulky mass resembling inflammatory pseudotumor. Report of three cases. Pathol Oncol Res. 2007;13:74–7.

    Article  PubMed  Google Scholar 

  20. Kim H, Dorfman RF, Rappaport H. Signet ring cell lymphoma. A rare morphologic and functional expression of nodular (follicular) lymphoma. Am J Surg Pathol. 1978;2:119–32.

    Article  CAS  PubMed  Google Scholar 

  21. Bouska A, Zhang W, Gong Q, Iqbal J, Scuto A, Vose J, et al. Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma. Leukemia. 2017;31:83–91.

    Article  CAS  PubMed  Google Scholar 

  22. Schmid U, Cogliatti SB, Diss TC, Isaacson PG. Monocytoid/marginal zone B-cell differentiation in follicle centre cell lymphoma. Histopathology. 1996;29:201–8.

    Article  CAS  PubMed  Google Scholar 

  23. Jaffe ES, Arber DA, Campo E, Harris NL, Quintanilla-Martinez L, editors. Hematopathology. 2nd ed. Philadelphia, PA: Elsevier; 2016.

    Google Scholar 

  24. Osborne BM, Butler JJ. Follicular lymphoma mimicking progressive transformation of germinal centers. Am J Clin Pathol. 1987;88:264–9.

    Article  CAS  PubMed  Google Scholar 

  25. Kojima M, Yamanaka S, Yoshida T, Shimizu K, Murayama K, Ohno Y, et al. Histological variety of floral variant of follicular lymphoma. APMIS. 2006;114:626–32.

    Article  PubMed  Google Scholar 

  26. Goates JJ, Kamel OW, LeBrun DP, Benharroch D, Dorfman RF. Floral variant of follicular lymphoma. Immunological and molecular studies support a neoplastic process. Am J Surg Pathol. 1994;18:37–47.

    Article  CAS  PubMed  Google Scholar 

  27. Pina-Oviedo S, Miranda RN, Lin P, Manning JT, Medeiros LJ. Follicular lymphoma with hyaline-vascular Castleman-like features: analysis of 6 cases and review of the literature. Hum Pathol. 2017;68:136–46.

    Article  PubMed  Google Scholar 

  28. Younes SF, Beck AH, Lossos IS, Levy R, Warnke RA, Natkunam Y. Immunoarchitectural patterns in follicular lymphoma: efficacy of HGAL and LMO2 in the detection of the interfollicular and diffuse components. Am J Surg Pathol. 2010;34:1266–76.

    Article  PubMed  Google Scholar 

  29. Mann RB, Berard CW. Criteria for the cytologic subclassification of follicular lymphomas: a proposed alternative method. Hematol Oncol. 1983;1:187–92.

    Article  CAS  PubMed  Google Scholar 

  30. El Behery R, Laurini JA, Weisenburger DD, Smith LM, Dave BJ, Yuan J, et al. Follicular large cleaved cell (centrocytic) lymphoma: an unrecognized variant of follicular lymphoma. Hum Pathol. 2018;72:180–90.

    Article  PubMed  Google Scholar 

  31. Montes-Moreno S, Roncador G, Maestre L, Martinez N, Sanchez-Verde L, Camacho FI, et al. Gcet1 (centerin), a highly restricted marker for a subset of germinal center-derived lymphomas. Blood. 2008;111:351–8.

    Article  CAS  PubMed  Google Scholar 

  32. Wang SA, Wang L, Hochberg EP, Muzikansky A, Harris NL, Hasserjian RP. Low histologic grade follicular lymphoma with high proliferation index: morphologic and clinical features. Am J Surg Pathol. 2005;29:1490–6.

    Article  PubMed  Google Scholar 

  33. Li Y, Hu S, Zuo Z, Hong M, Lin P, Li S, et al. CD5-positive follicular lymphoma: clinicopathologic correlations and outcome in 88 cases. Mod Pathol. 2015;28:787–98.

    Article  CAS  PubMed  Google Scholar 

  34. Mackrides N, Campuzano-Zuluaga G, Maque-Acosta Y, Moul A, Hijazi N, Ikpatt FO, et al. Epstein-Barr virus-positive follicular lymphoma. Mod Pathol. 2017;30:519–29.

    Article  CAS  PubMed  Google Scholar 

  35. Lambrechts AC, Hupkes PE, Dorssers LC, van’t Veer MB. Translocation (14;18)-positive cells are present in the circulation of the majority of patients with localized (stage I and II) follicular non-Hodgkin’s lymphoma. Blood. 1993;82:2510–6.

    Article  CAS  PubMed  Google Scholar 

  36. Nadel B, Marculescu R, Le T, Rudnicki M, Bocskor S, Jager U. Novel insights into the mechanism of t(14;18)(q32;q21) translocation in follicular lymphoma. Leuk Lymphoma. 2001;42:1181–94.

    Article  CAS  PubMed  Google Scholar 

  37. Horsman DE, Gascoyne RD, Coupland RW, Coldman AJ, Adomat SA. Comparison of cytogenetic analysis, southern analysis, and polymerase chain reaction for the detection of t(14; 18) in follicular lymphoma. Am J Clin Pathol. 1995;103:472–8.

    Article  CAS  PubMed  Google Scholar 

  38. Watanabe R, Tomita N, Matsumoto C, Hattori Y, Matsuura S, Takasaki H, et al. The 3q27 and 18q21 translocations for follicular lymphoma and diffuse large B-cell lymphoma in the rituximab era. J Clin Exp Hematop. 2013;53:107–14.

    Article  PubMed  Google Scholar 

  39. Karube K, Ying G, Tagawa H, Niino D, Aoki R, Kimura Y, et al. BCL6 gene amplification/3q27 gain is associated with unique clinicopathological characteristics among follicular lymphoma without BCL2 gene translocation. Mod Pathol. 2008;21:973–8.

    Article  CAS  PubMed  Google Scholar 

  40. Akasaka T, Lossos IS, Levy R. BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma. Blood. 2003;102:1443–8.

    Article  CAS  PubMed  Google Scholar 

  41. Green MR, Gentles AJ, Nair RV, Irish JM, Kihira S, Liu CL, et al. Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma. Blood. 2013;121:1604–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Ottensmeier CH, Thompsett AR, Zhu D, Wilkins BS, Sweetenham JW, Stevenson FK. Analysis of VH genes in follicular and diffuse lymphoma shows ongoing somatic mutation and multiple isotype transcripts in early disease with changes during disease progression. Blood. 1998;91:4292–9.

    Article  CAS  PubMed  Google Scholar 

  43. Jegalian AG, Eberle FC, Pack SD, Mirvis M, Raffeld M, Pittaluga S, Jaffe ES. Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma. Blood. 2011;118:2976–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Zenda T, Masunaga T, Fuwa B, Okada T, Ontachi Y, Kondo Y, et al. Small follicular lymphoma arising near the ampulla of vater: a distinct subtype of duodenal lymphoma? Int J Gastrointest Cancer. 2005;36:113–9.

    Article  PubMed  Google Scholar 

  45. Kitabatake H, Nagaya T, Tanaka N, Ota H, Sano K, Asano N, et al. Development of diffuse large B-cell lymphoma from follicular lymphoma of the duodenum: changes in endoscopic findings during a 6-year follow-up. Clin J Gastroenterol. 2017;10:79–85.

    Article  PubMed  Google Scholar 

  46. Seki A, Iwamuro M, Yoshioka M, Fujii N, Okada H, Nose S, et al. Primary duodenal follicular lymphoma treated with rituximab monotherapy and followed-up for 15 years. Acta Med Okayama. 2015;69:301–6.

    PubMed  Google Scholar 

  47. Takata K, Tanino M, Ennishi D, Tari A, Sato Y, Okada H, et al. Duodenal follicular lymphoma: comprehensive gene expression analysis with insights into pathogenesis. Cancer Sci. 2014;105:608–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Louissaint A Jr, Ackerman AM, Dias-Santagata D, Ferry JA, Hochberg EP, Huang MS, et al. Pediatric-type nodal follicular lymphoma: an indolent clonal proliferation in children and adults with high proliferation index and no BCL2 rearrangement. Blood. 2012;120:2395–404.

    Article  CAS  PubMed  Google Scholar 

  49. Liu Q, Salaverria I, Pittaluga S, Jegalian AG, Xi L, Siebert R, et al. Follicular lymphomas in children and young adults: a comparison of the pediatric variant with usual follicular lymphoma. Am J Surg Pathol. 2013;37:333–43.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Schmidt J, Ramis-Zaldivar JE, Nadeu F, Gonzalez-Farre B, Navarro A, Egan C, et al. Mutations of MAP2K1 are frequent in pediatric-type follicular lymphoma and result in ERK pathway activation. Blood. 2017;130:323–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Ozawa MG, Bhaduri A, Chisholm KM, Baker SA, Ma L, Zehnder JL, et al. A study of the mutational landscape of pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma. Mod Pathol. 2016;29:1212–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Finn LS, Viswanatha DS, Belasco JB, Snyder H, Huebner D, Sorbara L, et al. Primary follicular lymphoma of the testis in childhood. Cancer. 1999;85:1626–35.

    Article  CAS  PubMed  Google Scholar 

  53. Lones MA, Raphael M, McCarthy K, Wotherspoon A, Terrier-Lacombe MJ, Ramsay AD, et al. Primary follicular lymphoma of the testis in children and adolescents. J Pediatr Hematol Oncol. 2012;34:68–71.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Siddiqi IN, Friedman J, Barry-Holson KQ, Ma C, Thodima V, Kang I, et al. Characterization of a variant of t(14;18) negative nodal diffuse follicular lymphoma with CD23 expression, 1p36/TNFRSF14 abnormalities, and STAT6 mutations. Mod Pathol. 2016;29:570–81.

    Article  CAS  PubMed  Google Scholar 

  55. Katzenberger T, Kalla J, Leich E, Stocklein H, Hartmann E, Barnickel S, et al. A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36. Blood. 2009;113:1053–61.

    Article  CAS  PubMed  Google Scholar 

  56. Zamo A, Pischimarov J, Horn H, Ott G, Rosenwald A, Leich E. The exomic landscape of t(14;18)-negative diffuse follicular lymphoma with 1p36 deletion. Br J Haematol. 2018;180(3):391–4.

    Article  CAS  PubMed  Google Scholar 

  57. Pittaluga S, Harris NL, Siebert R, Salaverria I. Large B-cell lymphoma with IRF4 rearrangement. In: Swerdlow SH, Campo E, Harris NH, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO Classification of tumours of the haematopoietic and lymphoid tissues. 4th revised ed. Lyon: IARC; 2017. p. 280–1.

    Google Scholar 

  58. Karube K, Guo Y, Suzumiya J, Sugita Y, Nomura Y, Yamamoto K, et al. CD10-MUM1+ follicular lymphoma lacks BCL2 gene translocation and shows characteristic biologic and clinical features. Blood. 2007;109:3076–9.

    Article  CAS  PubMed  Google Scholar 

  59. Naresh KN. MUM1 expression dichotomises follicular lymphoma into predominantly, MUM1-negative low-grade and MUM1-positive high-grade subtypes. Haematologica. 2007;92:267–8.

    Article  PubMed  Google Scholar 

  60. Medeiros LJ, OMalley DP, Caraway N, Vega F, Elenitoba-Johnson KSJ, Lim MS. Tumors of the lymph nodes and spleen. AFIP; 2017.

    Google Scholar 

  61. Sorigue M, Sancho JM. Current prognostic and predictive factors in follicular lymphoma. Ann Hematol. 2018;97:209–27.

    Article  PubMed  Google Scholar 

  62. Kanagal-Shamanna R, Medeiros LJ, Lu G, Wang SA, Manning JT, Lin P, et al. High-grade B cell lymphoma, unclassifiable, with blastoid features: an unusual morphological subgroup associated frequently with BCL2 and/or MYC gene rearrangements and a poor prognosis. Histopathology. 2012;61:945–54.

    Article  PubMed  Google Scholar 

  63. Wafa A, Moassass F, Liehr T, Bhatt S, Aljapawe A, Al AW. A high complex karyotype involving eleven chromosomes including three novel chromosomal aberrations and monoallelic loss of TP53 in case of follicular lymphoma transformed into B-cell lymphoblastic leukemia. Mol Cytogenet. 2016;9:91.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Kridel R, Sehn LH, Gascoyne RD. Can histologic transformation of follicular lymphoma be predicted and prevented? Blood. 2017;130:258–66.

    Article  CAS  PubMed  Google Scholar 

  65. O’Shea D, O’Riain C, Taylor C, Waters R, Carlotti E, Macdougall F, et al. The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival. Blood. 2008;112:3126–9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  66. Pasqualucci L, Khiabanian H, Fangazio M, Vasishtha M, Messina M, Holmes AB, et al. Genetics of follicular lymphoma transformation. Cell Rep. 2014;6:130–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Pastore A, Jurinovic V, Kridel R, Hoster E, Staiger AM, Szczepanowski M, et al. Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry. Lancet Oncol. 2015;16:1111–22.

    Article  CAS  PubMed  Google Scholar 

  68. Gentles AJ, Alizadeh AA, Lee SI, Myklebust JH, Shachaf CM, Shahbaba B, et al. A pluripotency signature predicts histologic transformation and influences survival in follicular lymphoma patients. Blood. 2009;114:3158–66.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Cooper K, Haffajee Z. bcl-2 and p53 protein expression in follicular lymphoma. J Pathol. 1997;182:307–10.

    Article  CAS  PubMed  Google Scholar 

  70. Canioni D, Joseph L, Fabiani B, Chassagne-Clement C, Dartigues-Cuilleres P, Charlotte F, et al. Prognostic value of P53 and Myc protein expression in follicular lymphomas in the PRIMA Trial in the Lysa Group. Blood. 2017;130:1508.

    Google Scholar 

  71. Davies AJ, Lee AM, Taylor C, Clear AJ, Goff LK, Iqbal S, et al. A limited role for TP53 mutation in the transformation of follicular lymphoma to diffuse large B-cell lymphoma. Leukemia. 2005;19:1459–65.

    Article  CAS  PubMed  Google Scholar 

  72. Miao Y, Hu SM, Lu XY, Li SY, Wang W, Medeiros LJ, Lin P. Double-hit follicular lymphoma with MYC and BCL2 translocations: a study of 7 cases with a review of literature. Hum Pathol. 2016;58:72–7.

    Article  CAS  PubMed  Google Scholar 

  73. Johnson NA, Savage KJ, Ludkovski O, Ben-Neriah S, Woods R, Steidl C, et al. Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival. Blood. 2009;114:2273–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Aukema SM, van Pel R, Nagel I, Bens S, Siebert R, Rosati S, et al. MYC expression and translocation analyses in low-grade and transformed follicular lymphoma. Histopathology. 2017;71:960–71.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The University of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, TX, USA

    Ali Sakhdari & Roberto N. Miranda

  2. University of Toronto, Toronto, ON, Canada

    Ali Sakhdari

Authors
  1. Ali Sakhdari
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roberto N. Miranda
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Roberto N. Miranda .

Editor information

Editors and Affiliations

  1. Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Nathan H. Fowler

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Sakhdari, A., Miranda, R.N. (2020). Pathologic Features, Grading, and Variants of Follicular Lymphoma. In: Fowler, N. (eds) Follicular Lymphoma. Springer, Cham. https://doi.org/10.1007/978-3-030-26211-2_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-26211-2_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-26210-5

  • Online ISBN: 978-3-030-26211-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation